Case Study: Successful Strategies From a Late Clinical Stage Gene Therapy Product

Time: 9:30 am
day: Day One


  • How safety and efficacy were successfully demonstrated to the regulators after modifying the gene therapy product
  • The reasons behind selection of particular clinical trial endpoints
  • How challenges in meeting regulatory CMC challenges are being navigated